Management of atrial fibrillation

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 5, 2004, Pages 1127-1144

  Gelzer, Anna R M ^a   Kraus, Marc S ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL;

ANOREXIA; ARTIFICIAL HEART PACEMAKER; ASCITES; ATAXIA; ATRIOVENTRICULAR BLOCK; AUSCULTATION; BREEDING METHOD; CARDIOVERSION; CAT DISEASE; CLINICAL FEATURE; COUGHING; DIFFERENTIAL DIAGNOSIS; DOG DISEASE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; LETHARGY; MUSCLE WEAKNESS; NONHUMAN; PHYSICAL EXAMINATION; QT PROLONGATION; QUALITY OF LIFE; REVIEW; SEIZURE; THORAX RADIOGRAPHY; TREATMENT INDICATION; VETERINARY MEDICINE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CAT DISEASES; CATS; DOG DISEASES; DOGS; ELECTROCARDIOGRAPHY;

CANIS FAMILIARIS; FELIS CATUS;

EID: 4444346539     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2004.05.001     Document Type: Review

References (71)

1. Patterson D.F. Spontaneous abnormal cardiac arrhythmias and conduction disturbances in the dog (a clinical and pathologic study of 3000 dogs) Am J Vet Res 22 1931 355-369
2. De Rick A. Atrium fibrillatie bij de hond Vlaams Diergeneesk Tijdschr 49 1980 114-129
3. Lombard C.W. Atrial fibrillation in dogs: occurrence and clinical observations [in German] Schweiz Arch Tierheilkd 120 8 1978 393-407
4. Buchanan J.W. Spontaneous arrhythmias and conduction disturbances in domestic animals Ann NY Acad Sci 127 1 1965 224-238
5. Bonagura J.D. Ware W.A. Atrial fibrillation in the dog: clinical findings in 81 cases J Am Anim Hosp Assoc 22 1986 110-120
6. Collet M. A retrospective study of 14 cases of chronic atrial fibrillation without evidence of initial underlying cardiac disease in dogs Pratique de Medecine et Chirurgie des Animaux de Compagnie 10 2 2000 167-176
7. Brownlie S.E. An electrocardiographic survey of cardiac rhythm in Irish wolfhounds Vet Rec 129 21 1991 470-471
8. Tidholm A. Jonsson L. Dilated cardiomyopathy in the Newfoundland: a study of 37 cases (1983-1994) J Am Anim Hosp Assoc 32 6 1996 465-470
9. Meurs K.M. Miller M.W. Wright N.A. Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1990-2000) J Am Vet Med Assoc 218 5 2001 729-732
10. Vollmar A.C. The prevalence of cardiomyopathy in the Irish wolfhound: a clinical study of 500 dogs J Am Anim Hosp Assoc 36 2 2000 125-132
11. Brownlie S.E. Cobb M.A. Observations on the development of congestive heart failure in Irish wolfhounds with dilated cardiomyopathy J Small Anim Pract 40 8 1999 371-377
12. Harpster N.K. Cardiac arrhythmias in the Irish Wolfhound: preliminary study. In: Proceedings of the Annual Veterinary Medical Forum, San Francisco, CA. American College of Veterinary Internal Medicine; 1994. p. 319-324.
13. Bohn F.K. Patterson D.F. Pyle R.L. Atrial fibrillation in dogs Br Vet J 127 10 1971 485-496
14. Glaus T.M. Hassig M. Keene B.W. Accuracy of heart rate obtained by auscultation in atrial fibrillation J Am Anim Hosp Assoc 39 3 2003 237-239
15. Elhendy A. Gentile F. Khandheria B.K. Hammill S.C. Gersh B.J. Bailey K.R. et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation Am J Cardiol 89 1 2002 83-86
16. Saxonhouse S.J. Curtis A.B. Risks and benefits of rate control versus maintenance of sinus rhythm Am J Cardiol 91 6A 2003 27D-32D
17. Wyse D.G. Waldo A.L. DiMarco J.P. Domanski M.J. Rosenberg Y. Schron E.B. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 23 2002 1825-1833
18. Hohnloser S.H. Kuck K.H. Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 9244 2000 1789-1794
19. Gronefeld G.C. Lilienthal J. Kuck K.H. Hohnloser S.H. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study Eur Heart J 24 15 2003 1430-1436
20. Carlsson J. Miketic S. Windeler J. Cuneo A. Haun S. Micus S. et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 10 2003 1690-1696
21. Hagens V.E. Van Gelder I.C. Crijns H.J. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation Card Electrophysiol Rev 7 2 2003 118-121
22. Van Gelder I.C. Hagens V.E. Bosker H.A. Kingma J.H. Kamp O. Kingma T. et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 23 2002 1834-1840
23. Miyamoto M. Nishijima Y. Nakayama T. Hamlin R.L. Cardiovascular effects of intravenous diltiazem in dogs with iatrogenic atrial fibrillation J Vet Intern Med 14 4 2000 445-451
24. Miyamoto M. Nishijima Y. Nakayama T. Hamlin R.L. Acute cardiovascular effects of diltiazem in anesthetized dogs with induced atrial fibrillation J Vet Intern Med 15 6 2001 559-563
25. Hamlin R.L. What is the best heart rate for a dog in atrial fibrillation? In: Proceedings of the Annual Veterinary Medical Forum, Lake Buena Vista, FL, American College of Veterinary Internal Medicine. 1995. p. 325.
26. Marino D.J. Matthiesen D.T. Fox P.R. Lesser M.B. Stamoulis M.E. Ventricular arrhythmias in dogs undergoing splenectomy: a prospective study Vet Surg 23 2 1994 101-106
27. Miller R.H. Lehmkuhl L.B. Bonagura J.D. Beall M.J. Retrospective analysis of the clinical utility of ambulatory electrocardiographic (Holter) recordings in syncopal dogs: 44 cases (1991-1995) J Vet Intern Med 13 2 1999 111-122
28. Mason J.W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic study versus Electrocardiographic Monitoring Investigators N Engl J Med 329 7 1993 445-451
29. Morganroth J. Evaluation of antiarrhythmic therapy using Holter monitoring Am J Cardiol 62 12 Suppl 1988 18H-23H
30. Knoebel S.B. Williams S.V. Achord J.L. Reynolds W.A. Fisch C. Friesinger G.C. et al. Clinical competence in ambulatory electrocardiography. A statement for physicians from the AHA/ACC/ACP Task Force on Clinical Privileges in Cardiology Circulation 88 1 1993 337-341
31. Smith T.W. Digitalis. Mechanisms of action and clinical use N Engl J Med 318 6 1988 358-365
32. Pitcher D. Papouchado M. James M.A. Rees J.R. Twenty four hour ambulatory electrocardiography in patients with chronic atrial fibrillation BMJ (Clin Res Educ) 292 1986 594
33. Redfors A. Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation Acta Med Scand 190 4 1971 321-333
34. Goldenberg I.F. Lewis W.R. Dias V.C. Heywood J.T. Pedersen W.R. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure Am J Cardiol 74 9 1994 884-889
35. Materne P. Legrand V. Vandormael M. Collignon P. Kulbertus H.E. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function Am J Cardiol 54 7 1984 733-737
36. Pinter A. Dorian P. Paquette M. Ng A. Burns M. Spanu I. et al. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used J Cardiovasc Pharmacol Ther 8 1 2003 17-24
37. Fung J.W. Yu C.M. Kum L.C. Yip G.W. Sanderson J.E. Role of beta-blocker therapy in heart failure and atrial fibrillation Card Electrophysiol Rev 7 3 2003 236-242
38. Fung J.W. Chan S.K. Yeung L.Y. Sanderson J.E. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials Eur J Heart Fail 4 4 2002 489-494
39. Lechat P.P. Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II Analysis Card Electrophysiol Rev 7 3 2003 233-235
40. Hamlin R.L. Clinical use of diltiazem for dogs with atrial fibrillation [abstract]. In: Proceedings of the Annual Veterinary Medical Forum. American College of Veterinary Internal Medicine; 1988. p.759.
41. Hamann S.R. McAllister R.G. Jr. Cardiodepressant actions of combined diltiazem and propranolol in dogs J Cardiovasc Pharmacol 23 1 1994 31-36
42. Tse H.F. Lam Y.M. Lau C.P. Cheung B.M. Kumana C.R. Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation Clin Exp Pharmacol Physiol 28 5-6 2001 446-450
43. Delle Karth G. Geppert A. Neunteufl T. Priglinger U. Haumer M. Gschwandtner M. et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias Crit Care Med 29 6 2001 1149-1153
44. Calvert C.A. Sammarco C. Pickus C. Positive Coombs' test results in two dogs treated with amiodarone J Am Vet Med Assoc 216 12 2000 1926, 1933-6
45. Jacobs G. Calvert C. Kraus M. Hepatopathy in 4 dogs treated with amiodarone J Vet Intern Med 14 1 2000 96-99
46. Touboul P. Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation Am J Cardiol 83 5B 1999 241D-245D
47. Brignole M. Ablate and pace: palliating the symptoms? Am J Cardiol 86 9 Suppl 1 2000 K4-K8
48. Willems R. Wyse D.G. Gillis A.M. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy J Cardiovasc Electrophysiol 14 12 2003 1296-1301
49. Morris D.D. Fregin G.F. Atrial fibrillation in horses: factors associated with response to quinidine sulfate in 77 clinical cases Cornell Vet 72 4 1982 339-349
50. Falk R.H. Atrial fibrillation N Engl J Med 344 14 2001 1067-1078
51. Kingma J.H. Suttorp M.J. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil Am J Cardiol 70 5 1992 56A-60A, discussion 60A-1A
52. Reef V.B. Levitan C.W. Spencer P.A. Factors affecting prognosis and conversion in equine atrial fibrillation J Vet Intern Med 2 1 1988 1-6
53. Pyle R.L. Conversion of atrial fibrillation with quinidine sulfate in a dog J Am Vet Med Assoc 151 5 1967 582-589
54. Kittleson M.D. Kienle R.D. Diagnosis and treatment of arrhythmias Small animal cardiovascular Medicine 1998 469-493 Mosby St. Louis
55. Fors W.J. Jr. Vanderark C.R. Reynolds E.W. Jr. Evaluation of propranolol and quinidine in the treatment of quinidine-resistant arrhythmias Am J Cardiol 27 2 1971 190-194
56. Khan I.A. Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation Int J Cardiol 87 2-3 2003 121-128
57. McNamara R.L. Tamariz L.J. Segal J.B. Bass E.B. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography Ann Intern Med 139 12 2003 1018-1033
58. Volgman A.S. Carberry P.A. Stambler B. Lewis W.R. Dunn G.H. Perry K.T. et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation J Am Coll Cardiol 31 6 1998 1414-1419
59. Oral H. Souza J.J. Michaud G.F. Knight B.P. Goyal R. Strickberger S.A. et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment N Engl J Med 340 24 1999 1849-1854
60. Prystowsky E.N. Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why? Am J Cardiol 86 3 2000 326-327
61. Botto G.L. Politi A. Bonini W. Broffoni T. Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements Heart 82 6 1999 726-730
62. Scholten M. Szili-Torok T. Klootwijk P. Jordaens L. Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation Heart 89 9 2003 1032-1034
63. Mittal S. Stein K.M. Markowitz S.M. Iwai S. Guttigoli A. Lerman B.B. An update on electrical cardioversion of atrial fibrillation Card Electrophysiol Rev 7 3 2003 285-289
64. Frye M.A. Selders C.G. Mama K.R. Wagner A.E. Bright J.M. Use of biphasic electrical cardioversion for treatment of idiopathic atrial fibrillation in two horses J Am Vet Med Assoc 220 7 2002 1007, 1039-45
65. Joglar J.A. Hamdan M.H. Ramaswamy K. Zagrodzky J.D. Sheehan C.J. Nelson L.L. et al. Initial energy for elective external cardioversion of persistent atrial fibrillation Am J Cardiol 86 3 2000 348-350
66. Shah D.C. Haissaguerre M. Jais P. Catheter ablation of pulmonary vein foci for atrial fibrillation: PV foci ablation for atrial fibrillation Thorac Cardiovasc Surg 47 Suppl 3 1999 352-356
67. Jais P. Weerasooriya R. Shah D.C. Hocini M. Macle L. Choi K.J. et al. Ablation therapy for atrial fibrillation (AF): past, present and future Cardiovasc Res 54 2 2002 337-346
68. Fuster V. Ryden L.E. Asinger R.W. Cannom D.S. Crijns H.J. Frye R.L. et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) Developed in Collaboration with the North American Society of Pacing and Electrophysiology Circulation 104 17 2001 2118-2150
69. Savelieva I. Camm A.J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol 8 2 2003 103-115
70. Darbar D. Herron K.J. Ballew J.D. Jahangir A. Gersh B.J. Shen W.K. et al. Familial atrial fibrillation is a genetically heterogeneous disorder J Am Coll Cardiol 41 12 2003 2185-2192
71. Lai L.P. Lin J.L. Huang S.K. Molecular genetic studies in atrial fibrillation Cardiology 100 3 2003 109-113